On Wednesday, October 29th at 1:30PM PT, the IndieBio team is hitting the TechCrunch Disrupt Breakout Stage to talk through “Where Is Deep Tech is Headed?” (hint: it’s not just AI).
Deep tech is entering a new phase, one that extends beyond the AI hype cycle and into the physical and biological systems shaping our future. IndieBioSF invests in scientists turning lab breakthroughs into scalable companies across biomanufacturing, materials, energy, human health, and more.
In this session, IndieBio’s PhD-trained investors will share how they are adapting to longer timelines and capital-intensive roadmaps, while maintaining conviction in the science that can decarbonize, heal, and sustain the planet. Founders will leave with insights on how to translate deep science into durable, world-changing companies, starting at the very earliest stages.
Speakers:
- Westley Dang (Principal, PhD in Neuroscience in the lab of Mark Mayford at The Scripps Research Institute)
- Sierra Brooks (Senior Scientist & Analyst, BS in Chemical-Biological Engineering at MIT, PhD in Chemical Engineering from the University of Texas at Austin)
- Philipp Sander (Investment Analyst, PhD in Chemical Biology from the Scripps Research Institute in San Diego)
- Moderated by Po Bronson (General Partner)
